A leading innovative biopharmaceutical company in China Media Reports Company News Menu Media Reports Company News Tasly Biopharma signed license agreement with Sutro to introduce new ADC drug STRO-002 Read More » CCTV: Tasly Accelerates Its Drug Research and Development to Build a Line of Defense for Health Read More » Tasly Biopharma ranks second in the 2019 Future Healthcare VB 100 -Top 100 China Innovative Medicine List Read More »
CCTV: Tasly Accelerates Its Drug Research and Development to Build a Line of Defense for Health Read More »
Tasly Biopharma ranks second in the 2019 Future Healthcare VB 100 -Top 100 China Innovative Medicine List Read More »
